| 心通医疗-B |
CICC Capital Management Co., Ltd. |
增持 |
181592220 |
18159.22万股 |
0.08% |
好仓 |
2021-02-04 |
| XL二南方沪深三 |
Citigroup Inc. |
减持 |
-815000 |
3064.96万股 |
0.50% |
好仓 |
2021-02-04 |
| 中联重科 |
UBS Group AG |
增持 |
27500000 |
12158.20万股 |
0.08% |
好仓 |
2021-02-04 |
| 心通医疗-B |
China Renaissance Holdings Limited |
增持 |
191681040 |
19168.10万股 |
0.08% |
好仓 |
2021-02-04 |
| 洛阳钼业 |
UBS Group AG |
减持 |
-211482000 |
9175.99万股 |
0.02% |
好仓 |
2021-02-04 |
| 心通医疗-B |
Huajie (Tianjin) Medical Investment Partnership (Limited Partnership) (华杰(天津)医疗投资合伙企业(有限合伙)) |
增持 |
191681040 |
19168.10万股 |
0.08% |
好仓 |
2021-02-04 |
| 心通医疗-B |
Shanghai Huahao Enterprise Management Limited Partners (Limited Partnership) (上海铧浩企业管理合伙企业(有限合伙)) |
增持 |
191681040 |
19168.10万股 |
0.08% |
好仓 |
2021-02-04 |
| 心通医疗-B |
Tianjin Huajie Enterprise Management Advisors Partners, L.P. (天津华杰企业管理咨询合伙企业(有限合伙)) |
增持 |
191681040 |
19168.10万股 |
0.08% |
好仓 |
2021-02-04 |
| 心通医疗-B |
Tianjin Huaqing Enterprise Management Advisors Co., Ltd. (天津华清企业管理咨询有限公司) |
增持 |
191681040 |
19168.10万股 |
0.08% |
好仓 |
2021-02-04 |
| 心通医疗-B |
CICC Kangrui I (Ningbo) Equity Investment Limited Partners (Limited Partnership) |
增持 |
181592220 |
18159.22万股 |
0.08% |
好仓 |
2021-02-04 |
| 心通医疗-B |
CICC Kangzhi (Ningbo) Equity Investment Management Co., Ltd. |
增持 |
181592220 |
18159.22万股 |
0.08% |
好仓 |
2021-02-04 |
| 长安民生物流 |
BNP PARIBAS SA |
增持 |
3488000 |
348.80万股 |
0.06% |
好仓 |
2021-02-04 |
| 心通医疗-B |
Vstar Chuang Zhi Investment Limited |
增持 |
150000000 |
15000.00万股 |
0.06% |
好仓 |
2021-02-04 |
| 心通医疗-B |
Vstar SWHY Partners Limited |
增持 |
150000000 |
15000.00万股 |
0.06% |
好仓 |
2021-02-04 |
| 心通医疗-B |
Vstar SWHY Investment Fund Limited Partnership |
增持 |
150000000 |
15000.00万股 |
0.06% |
好仓 |
2021-02-04 |
| 心通医疗-B |
Vstar SWHY Investment Fund Limited Partnership |
增持 |
150000000 |
15000.00万股 |
0.06% |
好仓 |
2021-02-04 |
| 心通医疗-B |
Five Bulls International Holding Group |
增持 |
150000000 |
15000.00万股 |
0.06% |
好仓 |
2021-02-04 |
| 药明巨诺-B |
Juno Therapeutics, Inc. |
减持 |
-4665530 |
7023.11万股 |
0.18% |
好仓 |
2021-02-04 |
| 药明巨诺-B |
Celgene Corporation |
减持 |
-4665530 |
7023.11万股 |
0.18% |
好仓 |
2021-02-04 |
| 药明巨诺-B |
Bristol-Myers Squibb Company |
减持 |
-4665530 |
7023.11万股 |
0.18% |
好仓 |
2021-02-04 |
